A011040 Stock Overview
Kyung Dong Pharmaceutical Co., Ltd. produces and sells ethical, pharmaceutical ingredient, and non-prescription medicines in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Kyung Dong Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,400.00 |
| 52 Week High | ₩8,420.00 |
| 52 Week Low | ₩6,120.00 |
| Beta | 0.85 |
| 1 Month Change | 1.59% |
| 3 Month Change | 1.11% |
| 1 Year Change | -14.32% |
| 3 Year Change | -39.62% |
| 5 Year Change | -35.42% |
| Change since IPO | 293.98% |
Recent News & Updates
Recent updates
Is Kyung Dong Pharmaceutical (KOSDAQ:011040) A Risky Investment?
Mar 07
Consider This Before Buying Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040) For The 1.9% Dividend
Feb 18
Does Kyung Dong Pharmaceutical's (KOSDAQ:011040) Share Price Gain of 27% Match Its Business Performance?
Feb 03Does Kyung Dong Pharmaceutical's (KOSDAQ:011040) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 19Kyung Dong Pharmaceutical Co., Ltd.'s (KOSDAQ:011040) Dismal Stock Performance Reflects Weak Fundamentals
Jan 04How Much Of Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040) Do Insiders Own?
Dec 20We Think Kyung Dong Pharmaceutical (KOSDAQ:011040) Can Manage Its Debt With Ease
Dec 05Shareholder Returns
| A011040 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 1.3% | -0.2% | 1.0% |
| 1Y | -14.3% | 9.5% | 8.7% |
Return vs Industry: A011040 underperformed the KR Pharmaceuticals industry which returned 9.5% over the past year.
Return vs Market: A011040 underperformed the KR Market which returned 8.7% over the past year.
Price Volatility
| A011040 volatility | |
|---|---|
| A011040 Average Weekly Movement | 1.4% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A011040 has not had significant price volatility in the past 3 months.
Volatility Over Time: A011040's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | 385 | Deok-Hee Ryu | www.kdpharma.co.kr |
Kyung Dong Pharmaceutical Co., Ltd. produces and sells ethical, pharmaceutical ingredient, and non-prescription medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, cardiovascular and dysplidemia, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, antihistamine, CNS, antiobesity, NVP, neuropathic, osteoporosis, respiratory, allergy, and arthrifuge categories. The company also provides OTC medicines for pain/inflammation, cardiovascular, hepatic protectors, respiratory, gastrointestinal, calcium agent, vitamins and minerals, antihistamine, antifungal, antibiotic, otorhinolarynglogy agent, anti-inflammatory enzyme, dermatologic, hair solvents, antiviral, tonics, and contraceptive categories; and APIs and health functional foods, as well as quasi drugs.
Kyung Dong Pharmaceutical Co., Ltd. Fundamentals Summary
| A011040 fundamental statistics | |
|---|---|
| Market cap | ₩173.66b |
| Earnings (TTM) | -₩20.71b |
| Revenue (TTM) | ₩162.67b |
1.1x
P/S Ratio-8.4x
P/E RatioIs A011040 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A011040 income statement (TTM) | |
|---|---|
| Revenue | ₩162.67b |
| Cost of Revenue | ₩73.33b |
| Gross Profit | ₩89.34b |
| Other Expenses | ₩110.05b |
| Earnings | -₩20.71b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -763.17 |
| Gross Margin | 54.92% |
| Net Profit Margin | -12.73% |
| Debt/Equity Ratio | 6.6% |
How did A011040 perform over the long term?
See historical performance and comparison